Anemia
News
FDA approves deferiprone to treat iron overload
The FDA has approved deferiprone (Ferriprox) to treat iron overload in thalassemia patients who had an inadequate response to prior chelation...
News
FDA Approves Deferiprone for Transfusional Iron Overload
News
Team corrects SCD mutation with iPS cells
Using induced pluripotent stem (iPS) cells, researchers have corrected the genetic alteration that causes sickle cell disease (SCD). The...
News
Eculizumab gets accelerated approval for aHUS
News
Newly identified NHP2 biallelic mutation can cause dyskeratosis congenita
Copenhagen— Researchers have identified a new biallelic mutation in the telomerase component NHP2, which can cause the premature aging syndrome...
News
Eltrombopag increases platelet levels in chronic ITP
GENEVA—A recent trial shows that eltrombopag can, with minimal toxicity, improve platelet levels and reduce bleeding in patients with chronic...
News
Eculizumab decreases risk of thrombosis in PNH
Peter Hillmen, MD, of the Leeds Teaching Hospitals NHS Trust, reported the results of the study at the 12th Congress of the European Hematology...
News
Raising hemoglobin levels to normal range for chronic kidney failure patients may be too risky
Adverse events include death, arteriovenous access thrombosis, and poorly controlled hypertension. The investigators conducted a meta-analysis of...